S&P/ASX 200 Index (ASX: XJO) shares are up 0.4% to 9,039 points on Monday.

Among the 11 market sectors, energy is in the lead today, up 1.1%, while technology is the laggard, down 1.6%.

The financial sector led the market last week amid a bank share rally due to better-than-expected GDP data.

Let’s check out some new ratings on ASX shares today.

Megaport Ltd (ASX: MP1) 

The Megaport share price is $16.73, down 1.6% today and up 23% over 12 months. 

Ord Minnett has an accummulate rating on this ASX 200 tech share.

In a new note, the broker commented:  

Megaport’s (MP1) FY26 earnings and FY27 guidance exceeded consensus estimates. The company also announced three contract wins, together valued at $506 million. ‍

We believe the soft reaction to the results may have been because … ‍Some parts of the investment community had been expecting contract wins already, or more of a guidance uplift in guidance from GPU Pool monetisation.

We see guidance as prudent, and the EBITDA target is achievable purely on a conservative ramp-up of contracts without GPU Pool monetisation. 

Our target price is revised to $22. We have an Accumulate recommendation. Catalysts for the shares include upgrades to FY27 guidance and more contract wins.

Xero Ltd (ASX: XRO)

The Xero share price is $77.91, down 1.8% today and down 52% over 12 months. 

Blake Halligan from Gray Perry Wealth Advisers has a hold rating on this ASX 200 tech stock.

He said (courtesy The Bull):  

Xero remains a leading cloud accounting platform, with a dominant position in Australia and New Zealand.

Fiscal year 2026 operating revenue increased 31 per cent, supported by 506,000 net customer additions and the Melio Payments acquisition. Melio should aid in revenue growth, but costs associated with its integration contributed to a 27 per cent fall in net profit after tax and a gross margin decline from 89 per cent to 83.9 per cent.

The profitable ANZ and UK businesses offer growth potential and could assist in a continuing share price recovery.

AMP Ltd (ASX: AMP)

The AMP share price is $2.47, down 0.4% today and up 45% over 12 months. 

Halligan has a sell rating on this ASX 200 financial share.

He explained:

This wealth management company’s turnaround has gained momentum, with underlying net profit after tax (NPAT) increasing 33 per cent in the first half of 2026.

The simplified business, growing North platform and further capital returns are positives. However, much of this improvement appears reflected in the share price. AMP Bank also faces intense mortgage competition, higher funding costs and investment requirements.

The shares have risen from $1.16 on March 12 to trade at $2.475 on September 3.

The recent share price strength provides an opportunity to reallocate capital elsewhere, as restructuring and execution risks still remain.

The post Buy, hold, sell: Megaport, Xero, AMP shares appeared first on The Motley Fool Australia.

More reading

• These ASX 50 shares have lost up to 60%. Is the sell-off overdone?
• How to build a winning ASX share portfolio and create wealth
• ASX 200 bank shares led a financial sector rebound last week
• A 50% upside? This ASX 200 tech stock is back on my buy list
• This ASX 200 tech giant is down 30% in 2026. Can it make a comeback?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Bubs Australia Ltd (ASX: BUB) shares have returned from their trading halt with a bang on Monday.

At the time of writing, the infant formula stock is up 40% to 14 cents, after trading as high as 14.5 cents earlier this morning.

That is quite a turnaround. Bubs shares were down around 27% in 2026 when trading was halted on Friday. After today’s jump, the stock is now slightly higher for the year.

So, what has sent Bubs shares flying today?

The wait is finally over

According to the release, Bubs has secured permanent regulatory authorisation from the US Food and Drug Administration (FDA).

The approval covers 3 infant formula products: Bubs Goat, Bubs 365 Day Grass Fed, and Bubs Essential.

It confirms that the products, manufacturing systems, and supporting scientific evidence meet US requirements around safety, nutritional adequacy, and quality.

It also makes Bubs the only Australian infant formula brand, and one of a limited number of international manufacturers, permanently authorised to supply the US market.

CEO Joe Coote called it a “transformational milestone” and said the approval gives Bubs a platform to accelerate its US growth strategy.

The decision could also support a broader product range and possible entry into the US private-label infant nutrition market.

Why this is such a big deal

The US is already Bubs’ biggest market.

US revenue rose 24% to $65.8 million in FY26, out of total group revenue of $111.9 million. Its products are also now sold in more than 10,000 stores across the country.

Until now, Bubs had been able to continue selling in the US while the FDA worked through its review.

That process is now complete, removing one of the biggest uncertainties hanging over the business.

With well over half of group revenue now coming from the US, securing permanent approval is a major step for the company.

The director buying is worth a look

There’s another detail here that stands out.

Bubs chair Paul Jensen bought 1.5 million shares across 31 August and 1 September, paying between 8.55 cents and 8.7 cents per share.

In total, he spent around $130,500 just days before today’s FDA announcement.

And Jensen has been buying Bubs shares for some time. He also bought 1 million shares across 3 on-market trades in March, after picking up another 630,890 shares across 2 trades last September.

At today’s 14-cent share price, his latest 1.5 million shares are worth around $210,000. That’s roughly $80,000 more than he paid.

But he wasn’t the only director buying last week. Pascal De Petrini bought 800,000 shares, while Lori Tauber Marcus purchased her first 100,000 shares at 9.5 cents each.

The post Bubs shares just rocketed 40%. Here’s the news investors were waiting for appeared first on The Motley Fool Australia.

More reading

• This ASX share jumped 7% before a trading halt. What’s going on?
• How high do brokers think Bubs Australia shares will go?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Boresight Ltd (ASX: BST) shares traded more than 10% higher early on Monday after the company announced a repeat order from a major North American military contractor worth more than half a million dollars.

The purchase order is three times larger than previous orders from this customer, Boresight said, and consists of more than 340 BQ-400 swarming-capable aerial target drones, multiple ground control stations and an operator training course.

Drone warfare training the focus

Boresight, which listed on the ASX in June, supplies militaries and other customers with target drones for use in battlefield training.

The company said the new purchase was the large single order to date from a North American military.

Boresight Managing director Justin Olde said:

This repeat order is testament to the ongoing effectiveness of Boresight’s aerial target drones in providing cost-effective, reliable and repeatable mission counter drone training. We have a number of North American military customers however this particular client is a standard setting, training focused organisation that has broad influence over their entire military. They’ve looked at the available options and they keep coming back to Boresight. The ability to service this and other North American customers directly from our US facility means that our delivery lead times and costs are reduced, providing more responsiveness whilst driving down overheads. Support for this delivery will be provided from our Australian HQ where required, while we continue to ramp up operations at our expanded US facility.  

Delivery and payment is expected in the second quarter of FY27.

ASX listing designed to spur growth

Boresight, which was incorporated in 2020, raised $8 million ahead of its June listing on the ASX.

The company said its goal was, “to provide low-cost aerial drone targets to service western and allied militaries as they tackle how to respond to the rapidly changing battlespace”.

The company said further:

Military customers require a cost-effective and reliable way to evaluate counter drone technologies. Once these capabilities are deployed, they must develop effective tactics, techniques and procedures (TTP’s) for their use, and undertake continuous training to ensure that personnel are properly trained, and maintain those skills, throughout the life of the technology. To achieve this, customers require low-cost, disposable training drones (targets) – and lots of them. Boresight was created to meet that need.

Boresight said at the time it had sold more than 6,000 drones to customers globally since its launch and had offices in the US, the United Kingdom, and Australia.

Boresight shares were changing hands for 36 cents on Monday morning, up 14.3%.

The company is valued at $39.9 million.

The post Which ASX drone company is surging more than 10%? appeared first on The Motley Fool Australia.

More reading

• Experts reckon this high-flying ASX 200 blue-chip stock is a buy
• 5 things to watch on the ASX 200 on Monday
• ASX 200 bank shares led a financial sector rebound last week
• What’s driving the ASX 200 higher today?
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.